Skip to main content
OpenTrials

Clinical trial condition

Haemophilia B

Explore clinical trials studying Haemophilia B. Study availability and eligibility vary by location and protocol.

45 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Haemophilia B trial results

Completed

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B

NCT03075670

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Chicago, Illinois, United States
  • Novo Nordisk Investigational Site Peoria, Illinois, United States
  • Novo Nordisk Investigational Site East Lansing, Michigan, United States
View Trial Details
Completed

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

NCT03741881

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +12 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Sacramento, California, United States
  • Novo Nordisk Investigational Site Aurora, Colorado, United States
  • Novo Nordisk Investigational Site Washington D.C., District of Columbia, United States
View all 143 locations
View Trial Details
Completed

A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia

NCT03660774

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Orange, California, United States
  • Novo Nordisk Investigational Site San Diego, California, United States
  • Novo Nordisk Investigational Site Aurora, Colorado, United States
View all 22 locations
View Trial Details
Completed

Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B

NCT01228669

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +12 more
Locations
  • Novo Nordisk Investigational Site Vienna, Austria
  • Novo Nordisk Investigational Site Copenhagen, Denmark
  • Novo Nordisk Investigational Site Berlin, Germany
  • Novo Nordisk Investigational Site Frankfurt/M., Germany
View all 16 locations
View Trial Details
Completed

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

NCT01395810

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site San Francisco, California, United States
  • Novo Nordisk Investigational Site Washington D.C., District of Columbia, United States
  • Novo Nordisk Investigational Site Jacksonville, Florida, United States
View all 49 locations
View Trial Details
Completed

An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients

NCT02231944

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Klinika Hematologii Instytutu Medycyny Wewnetrznej Lodz, Poland
  • Klinika Hematologii AM Lublin, ul.Jaczewskiego 8 Lublin, Poland
  • Addenbrooke's Hospital, Hills Road Cambridge, United Kingdom
  • University Hospital of Wales, Heath Park Cardiff, United Kingdom
View Trial Details
Completed

An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery

NCT02250573

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Samodzielny Publiczny Zaklad Opieki Zdrowotnej nad Matka I Dzieckiem, ul. Krysiewicza 7/8. Poznan, Poland
  • Institutul National de Haemtologie, 2-8 Constantin Caracas Str. Bucharest, Romania
  • Spitalul de urgenta pentru copii "Louis Turcana", Str. losef Nemoianu 2. Timișoara, Romania
  • Kirov Research Institute of Haematology, 72 Krasnoarmeyskaya ul. Kirov, Russia
View Trial Details
Completed

A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery.

NCT02250560

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • North Hampshire Haemophilia Centre, Uplands House, North Hampshire Hospital, Aldermaston Road Basingstoke, United Kingdom
  • Haemophilia Centre, The Royal London Hospital, White Chapel London, United Kingdom
  • Haemophilia Centre and Haemostasis Unit, Royal Free Hospital, Pond Street London, United Kingdom
  • Manchester Thrombosis and Haemostasis Centre, University of Manchester, Department of Haematology, Manchester Royal Infirmary, Oxford Road Manchester, United Kingdom
View Trial Details
Completed

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

NCT01386528

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site San Francisco, California, United States
  • Novo Nordisk Investigational Site Washington D.C., District of Columbia, United States
  • Novo Nordisk Investigational Site Augusta, Georgia, United States
View all 41 locations
View Trial Details
Completed

Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients

NCT01333111

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Jacksonville, Florida, United States
  • Novo Nordisk Investigational Site Augusta, Georgia, United States
  • Novo Nordisk Investigational Site Iowa City, Iowa, United States
View all 43 locations
View Trial Details

Related conditions